首页> 中文期刊> 《功能材料》 >生物相容壳聚糖/蒙脱土复合微球的溶胀与药物缓释性能研究

生物相容壳聚糖/蒙脱土复合微球的溶胀与药物缓释性能研究

         

摘要

Chitosan/montmorillonite composite microspheres with good biocompatibility were prepared by in-verse emulsion polymerization, and modified montmorillonite was introduced as intercalation modifier. The structure of modified montmorillonite was analyzed by X-ray diffraction and infrared spectroscopy. Drug-loaded chitosan/montmorillonite microspheres were prepared with aspirin as the model drug by drug entrapment meth-od and drug release properties were discussed. The results are as follows. The interlayer distance of modified montmorillonite becomes larger. The swelling rate and drug release rate of composite microspheres reduces with the content of montmorillonite increasing. The release mode of drug-loaded chitosan/montmorillonite mi-crospheres is Fickian diffusion type at pH1. 2. The release mode is non-Fickian diffusion type at pH7. 4, Chi-tosan/montmorillonite composite microspheres have great potential as a drug carrier.%利用反相乳液聚合法制备出具有良好生物相容性的壳聚糖/蒙脱土复合微球,其中改性蒙脱土作为插层改性剂引入.用X射线衍射和红外光谱分析了改性蒙脱土的结构,以阿司匹林为模型药物,以药物包埋法制备出了壳聚糖/蒙脱土载药微球,并对其缓释性能进行探讨.结果表明,改性蒙脱土的层间距变大,随着蒙脱土含量的增大,复合微球的溶胀率降低,释药率逐渐减小,pH值为1.2下的壳聚糖/蒙脱土载药微球的释药模式为Fickian扩散类型,pH值为7.4下的释药模式为non Fickian扩散,壳聚糖/蒙脱土复合微球作为药物载体很有潜力.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号